Zentek Ltd. (NASDAQ:ZTEK - Get Free Report) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 148,000 shares, a drop of 25.1% from the February 13th total of 197,500 shares. Based on an average daily trading volume, of 45,800 shares, the days-to-cover ratio is presently 3.2 days. Currently, 0.2% of the company's stock are sold short.
Zentek Stock Up 1.8 %
Shares of NASDAQ:ZTEK traded up $0.02 during mid-day trading on Wednesday, hitting $0.92. 9,187 shares of the company traded hands, compared to its average volume of 37,956. The firm has a market cap of $95.97 million, a P/E ratio of -13.14 and a beta of 1.30. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.48 and a current ratio of 1.83. Zentek has a 52-week low of $0.50 and a 52-week high of $1.34. The firm's 50 day simple moving average is $1.05 and its 200 day simple moving average is $0.95.
Zentek (NASDAQ:ZTEK - Get Free Report) last announced its earnings results on Wednesday, February 12th. The company reported ($0.01) EPS for the quarter. Zentek had a negative net margin of 16,555.32% and a negative return on equity of 58.13%.
Institutional Investors Weigh In On Zentek
Hedge funds have recently modified their holdings of the stock. Two Sigma Securities LLC purchased a new stake in shares of Zentek during the 4th quarter valued at about $31,000. Anson Funds Management LP purchased a new stake in shares of Zentek during the 4th quarter valued at about $145,000. Finally, Scotia Capital Inc. increased its holdings in Zentek by 5.7% during the 4th quarter. Scotia Capital Inc. now owns 958,771 shares of the company's stock worth $867,000 after purchasing an additional 51,744 shares during the last quarter. 0.77% of the stock is currently owned by hedge funds and other institutional investors.
About Zentek
(
Get Free Report)
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.
Further Reading
Before you consider Zentek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.
While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
